Long-term outcome in adults with a previous Ross operation: a cohort studyShow others and affiliations
2026 (English)In: Open heart, E-ISSN 2053-3624, Vol. 13, no 1, article id e003782Article in journal (Refereed) Published
Abstract [en]
Introduction In aortic valve disease, several interventions are available. In young people who are still growing, or considering the risks of long-term anticoagulation, the Ross procedure remains an alternative for aortic valve replacement. This procedure entails the transposition of the patient's pulmonary valve to the aortic position, with placement of a homograft in the pulmonary position. However, long-term prognosis remains largely unknown. Methods The Swedish national registry of congenital heart disease was searched for adult patients with a history of Ross operation. Results 82 patients (mean age 40.4 +/- 15.8 years) were identified, with a mean age at the time of the Ross procedure of 23.6 +/- 14.7 years. After a mean follow-up of 16.8 +/- 5.5 years, 24.4% of patients underwent a first reoperation involving either the neoaortic valve or the pulmonary homograft, at a mean age of 32.0 +/- 13.9 years. The cumulative incidence of reoperation was approximately 15% at 10 years and 30% at 20 years post-Ross procedure. Among the 20 reinterventions, 17 (85.0%) involved the pulmonary valve and 8 the neoaortic valve; five patients underwent procedures on both valves. Two patients (2.3%) died during follow-up. Forty-eight patients in the cohort had undergone primary Ross surgery. This subgroup was older at the time of data extraction (mean age 46.7 +/- 15.7 years) compared with those who underwent secondary Ross surgery (mean age 31.3 +/- 10.7 years), that is, typically following previous interventions. The secondary Ross group demonstrated better left ventricular function, with ejection fraction >50% in 91.7% of cases, compared with 69.8% in the primary group (p=0.041). Conclusion One in four patients undergoing the Ross procedure requires a reintervention, commonly involving the pulmonary valve. Long-term mortality was low. In selected patients, the Ross procedure remains a viable option; however, late morbidity must be considered. Our findings suggest that secondary Ross surgery is associated with better long-term outcomes, particularly regarding left ventricular function, although the underlying mechanisms remain unclear.
Place, publisher, year, edition, pages
BMJ PUBLISHING GROUP , 2026. Vol. 13, no 1, article id e003782
Keywords [en]
Heart Valve Prosthesis Implantation; Epidemiology; Heart Defects, Congenital; Aortic Valve Stenosis
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:liu:diva-223317DOI: 10.1136/openhrt-2025-003782ISI: 001743495700001PubMedID: 41997619Scopus ID: 2-s2.0-105040363438OAI: oai:DiVA.org:liu-223317DiVA, id: diva2:2056094
Note
Funding Agencies|Ume Universitet; Vsterbotten Lns Landsting [RV-996417]; Visare Norr [994832]; Hjrt-Lungfonden [2023-0593]
2026-04-282026-04-282026-06-27